Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2025-12-24 @ 12:46 PM
NCT ID:
NCT04252261
Eligibility Criteria:
Inclusion Criteria:
* 18-65 years old
* Focal lesions were confined to the frontal brain, which is verified by CT or MRI
* Clinical diagnosis of Cognitive deficits using the Chinese version of the Montreal Cognitive Assessment (MoCA-C) with scores \< 26 will be assessed as having cognitive deficits (\<25 for patients educated \<12 years)
* be adherent to the continued sulforaphane treatment medication
Exclusion Criteria:
* Previous history of cognitive impairment
* Brain MRI indicating damage was not restricted to the frontal lobe.
* Inability to cooperate with cognitive testing for disturbance of consciousness or mental disorder
* Pregnancy or maternal lactation
* Life expectancy \< 3 months
* CO poisoning, autoimmune encephalitis, intracranial infection, or other types of diffuse intracranial disease.
* plan to receive radiotherapy during the trial period
* Laboratory examination showing liver and kidney insufficiency or other severe complications; the presence of diseases which may interfere with the results of the evaluation
* Involvement in other trials 1 month prior to the start of the trial or during the trial period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04252261
Study Brief:
Protocol Section:
NCT04252261